Name:
Institution:
Type:
PI
We aim to markedly expand access of all Californians to outstanding cell and gene therapy trials for multiple conditions with unmet treatment needs. We will also contribute with excellence to the other network sites in advancing all aspects of regenerative medicine.
As an ASCC, we will help advance the field for multiple diseases with unmet needs to bring novel treatments to patients. Californians with devastating conditions will be able to enroll in early and later stage cell and gene therapy clinical trials.